NXL

Nexalin Technology, Inc.

Healthcare · Medical Devices

$87.82 sample

+1.57 (+1.82%) 1D

Market cap

$234.2B

Price as of

2026-10-04

Latest filing

8-K · 2026-09-15

Alerts

8

Price$87.82 -2.23% 3M daily closessample

91.6684.62

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 25INSInsider buy: Chief Executive Officer
Sep 22INSInsider sell: Chief Executive Officer
Sep 15SEC10-Q filed
Sep 09INSInsider sell: General Counsel
Aug 31INSInsider sell: Chief Executive Officer
Aug 20SECDEF 14A filed
Aug 14INSInsider sell: Chief Financial Officer
Aug 11SEC8-K filed: material event

Sign up to see the real NXL record →

Company facts

SEC EDGAR registration

Name: Nexalin Technology, Inc.
Sector: Healthcare
Industry: Medical Devices
Smart-money score: -51sample, -100 to +100
Reporting currency: USD

Who is positioning in NXL

sample

Insiders: 9 insider transactions over 90 days, net selling, $241.3M
Congress: 3 members traded over 90 days
Institutions · 13F: 7 funds hold $1.6B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$6.1B +19.7% y/y

Q4 2024Q3 2026

Inventory$3.7B +15.4% y/y

Q4 2024Q3 2026

Accounts receivable$2.8B +8.8% y/y

Q4 2024Q3 2026

Total debt$7.3B +17.9% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $200.3B +6.4% 3M
Sample peer B: $200.8B -3.7% 3M
Sample peer C: $57.0B -8.4% 3M
Sample peer D: $139.7B +9.8% 3M
Sample peer E: $123.3B -2.5% 3M